
FDA OKs new monthly treatment for rare swelling disorder
The FDA has approved a first-of-its-kind treatment for a rare genetic condition that causes frequent, unpredictable, and painful swelling in different parts of the body. The drug, known as garadacimab but sold under the name Andembry, is used to prevent …